IXICO plc (LON:IXI – Get Free Report) crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 7.81 and traded as low as GBX 7.15. IXICO shares last traded at GBX 7.15, with a volume of 143 shares trading hands.
IXICO Price Performance
The company has a debt-to-equity ratio of 5.22, a current ratio of 2.83 and a quick ratio of 4.90. The firm has a market cap of £16.20 million, a price-to-earnings ratio of -3.79, a PEG ratio of -0.38 and a beta of 0.11. The stock has a 50-day moving average price of GBX 7.79 and a 200 day moving average price of GBX 7.85.
Insider Transactions at IXICO
In other news, insider Mark Warne purchased 50,006 shares of the business’s stock in a transaction on Wednesday, July 15th. The shares were bought at an average price of GBX 8 per share, with a total value of £4,000.48. 3.07% of the stock is owned by corporate insiders.
IXICO Company Profile
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Further Reading
- Five stocks we like better than IXICO
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
